In this study, we established and characterized novel iPSC lines from a patient with Xeroderma Pigmentosum group C (XP-C), harboring a homozygous loss-of-function mutation in the XPC gene (c.1830C>A, p.Tyr610*). The gene discussed is XPC; the disease is Xeroderma pigmentosum complementation group C.